Thank you to the #VJDementia and Dr. James Galvin for taking time out of a busy #ADPD2026 to discuss results from our Phase 2 study of #zervimesine in #dementia with Lewy bodies (DLB): lnkd.in/e_9Cw3N2.
#DementiaWithLewyBodies #DLBPsychosis #DementiaSupport #LewyStrong #Hallucinations #Delusions
$CGTX reported 4Q and YE2025 financial results last week: ir.cogrx.com/events/. During the webcast, CEO Lisa Ricciardi commented on the high level of interest in #zervimesine among participants in the DLB expanded access program.
#ClinicalResearch #DementiaWithLewyBodies #DLBPsychosis #LewyStrong
The #CGTX team is presenting an analysis at #ADPD2026 showing that Phase 2 'SHIMMER' #DLB participants on #zervimesine had a 102% slowing of decline relative to placebo. #Pressrelease: tinyurl.com/26rh26be
#DementiaWithLewyBodies #LewyBodyDementia #Dementia #LewyStrong #Psychosis #Neuroscience
No more armchair activism. I’m joining others at Minnesota Stare Capitol today to advocate for federal funding for dementia programs and research. Dementia is not a partisan issue #endalz #lewystrong 💟
www.alz.org/mnnd/events#....